These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 10959704)

  • 41. Increased urokinase and consumption of α
    Longstaff C; Locke M
    J Thromb Haemost; 2019 Jan; 17(1):195-205. PubMed ID: 30451372
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
    Guimarães AH; Rijken DC
    Thromb Haemost; 2004 Mar; 91(3):473-9. PubMed ID: 14983222
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Conversion of proteolytically modified form (Lys-form) of human plasminogen to plasmin by urokinase in the presence of tranexamic acid.
    Takada A; Takada Y
    Thromb Res; 1981 Aug 15-Sep 1; 23(4-5):411-9. PubMed ID: 6459659
    [No Abstract]   [Full Text] [Related]  

  • 44. Mechanism of action and some properties of a tissue activator of plasminogen.
    McCall DC; Kline DL
    Thromb Diath Haemorrh; 1965 Sep; 14(1-2):116-26. PubMed ID: 16955970
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Suppression of argatroban-induced endogenous thrombolysis by PKSI-527, and antibodies to TPA and UPA, evaluated in a rat arterial thrombolysis model.
    Hashimoto M; Oiwa K; Matsuo O; Ueshima S; Okada K; Okada Y; Okamoto S; Giddings JC; Yamamoto J
    Thromb Haemost; 2003 May; 89(5):820-5. PubMed ID: 12719778
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Conversion of Glu-plasminogen to plasmin by urokinase in the presence of tranexamic acid.
    Takada A; Takada Y
    Thromb Res; 1981 May; 22(4):437-43. PubMed ID: 6457415
    [No Abstract]   [Full Text] [Related]  

  • 47. Effects of a fucoidan on the activation of plasminogen by u-PA and t-PA.
    Nishino T; Yamauchi T; Horie M; Nagumo T; Suzuki H
    Thromb Res; 2000 Sep; 99(6):623-34. PubMed ID: 10974349
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.
    Vines DJ; Lee SW; Dichek DA; Ellis V
    J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The autoimmune blistering skin disease bullous pemphigoid. The presence of plasmin/alpha 2-antiplasmin complexes in skin blister fluid indicates plasmin generation in lesional skin.
    Kramer MD; Reinartz J
    J Clin Invest; 1993 Aug; 92(2):978-83. PubMed ID: 7688770
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of staphylokinase concentration of plasminogen activation.
    Arai K; Mimuro J; Madoiwa S; Matsuda M; Sako T; Sakata Y
    Biochim Biophys Acta; 1995 Aug; 1245(1):69-75. PubMed ID: 7654768
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasminogen assay by means of the lysis time method.
    Berg W; Korsan-Bengtsen K; Ygge J
    Thromb Diath Haemorrh; 1965 Sep; 14(1-2):127-44. PubMed ID: 16955971
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interaction of plasmin with alpha 2-macroglobulin and alpha 2-antiplasmin in the presence and absence of tranexamic acid.
    Takada A; Takada Y
    Thromb Res; 1980 Apr 1-15; 18(1-2):237-46. PubMed ID: 6157220
    [No Abstract]   [Full Text] [Related]  

  • 53. [Inhibition by ethanol and acetaldehyde the plasmin activity and plasminogen activation induced by urokinase and streptokinase].
    Roszkowska-Jakimiec W; Jurkowski J; Ostrowska H; Worowski K
    Rocz Akad Med Bialymst (1989); 1988-1989; 33-34():53-66. PubMed ID: 2979011
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interaction of SK-human plasmin, SK-dog plasmin complexes with alpha 2-antiplasmin and alpha 2-macroglobulin.
    Reddy KN; Cercek B; Lew AS; Ganz W
    Thromb Res; 1986 Mar; 41(5):671-80. PubMed ID: 2421434
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interaction of human plasmin with human alpha 2-macroglobulin.
    Cummings HS; Castellino FJ
    Biochemistry; 1984 Jan; 23(1):105-11. PubMed ID: 6197993
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasmin generation induces neutrophil aggregation: dependence on the catalytic and lysine binding sites.
    Ryan TJ; Lai L; Malik AB
    J Cell Physiol; 1992 May; 151(2):255-61. PubMed ID: 1533399
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Denatured proteins as cofactors for plasminogen activation.
    Machovich R; Owen WG
    Arch Biochem Biophys; 1997 Aug; 344(2):343-9. PubMed ID: 9264548
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of the invasion-metastasis mechanism in pancreatic cancer: involvement of plasmin(ogen) cascade proteins in the invasion of pancreatic cancer cells.
    Tan X; Egami H; Nozawa F; Abe M; Baba H
    Int J Oncol; 2006 Feb; 28(2):369-74. PubMed ID: 16391791
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of plasmin binding and urokinase activation of plasminogen bound to the Heymann nephritis autoantigen, gp330.
    Kanalas JJ
    Arch Biochem Biophys; 1992 Dec; 299(2):255-60. PubMed ID: 1280065
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Electrochemical assay of plasmin activity and its kinetic analysis.
    Ohtsuka K; Maekawa I; Waki M; Takenaka S
    Anal Biochem; 2009 Feb; 385(2):293-9. PubMed ID: 19041631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.